Hu (Human), Bov (Bovine), Can (Canine), Ms (Mouse), Rb (Rabbit), Ze (Zebrafish), Rt (Rat), African clawed frog, Eq (Equine), GP (Guinea Pig), Gt (Goat), Por (Porcine), Ye (Yeast)
Available hosts
Mouse, Rabbit
Available applications
Enzyme Immunoassay (E), Immunocytochemistry/Immunofluorescence (ICC/IF), Western blot / Immunoblot (WB), Paraffin Sections (P)
Background of Splicing factor 1 (SF1) antibody
Kit Component:
- KN205846G1, SF1 gRNA vector 1 in pCas-Guide vector - KN205846G2, SF1 gRNA vector 2 in pCas-Guide vector - KN205846D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette - GE100003, scramble sequence in pCas-Guide vector
Human HepG2; WB Suggested Anti-SF1 Antibody Titration: 1.25ug/ml. ELISA Titer: 1:312500. Positive Control: HepG2 cell lysate. SF1 is supported by BioGPS gene expression data to be expressed in HepG2.; SF1 antibody - N-terminal region (ARP41214_T100) in Human HepG2 cells using Western Blot
Human HepG2; WB Suggested Anti-SF1 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:62500. Positive Control: HepG2 cell lysate. SF1 is supported by BioGPS gene expression data to be expressed in HepG2.; SF1 antibody - C-terminal region (ARP41212_P050) in Human HepG2 cells using Western Blot
Human Jurkat; WB Suggested Anti-SF1 Antibody Titration: 0.2-1 ug/ml. Positive Control: Jurkat cell lysate. SF1 is supported by BioGPS gene expression data to be expressed in Jurkat.; SF1 antibody - C-terminal region (ARP41213_P050) in Human Jurkat cells using Western Blot
Human COLO205; WB Suggested Anti-SF1 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:12500. Positive Control: COLO205 cell lysate. SF1 is supported by BioGPS gene expression data to be expressed in COLO205.; SF1 antibody - middle region (ARP33493_P050) in Human COLO205 cells using Western Blot
Immunohistochemistry analysis of paraffin-embedded human brain, using SF1 (Phospho-Ser82) Antibody. The picture on the right is treated with the synthesized peptide.
Western blot analysis of extracts from HuvEc cells treated with anisomycin 25ug/ml 30', using SF1 (Phospho-Ser82) Antibody. The lane on the right is treated with the synthesized peptide.
Immunohistochemistry analysis of paraffin-embedded human brain tissue, using SF1 (Ab-82) Antibody. The picture on the right is treated with the synthesized peptide.
Human Jurkat; WB Suggested Anti-SF1 Antibody. . Titration: 1.0 ug/ml. . Positive Control: Jurkat Whole Cell. SF1 is supported by BioGPS gene expression data to be expressed in Jurkat.; SF1 antibody - N-terminal region (ARP33492_P050) in Human Jurkat cells using Western Blot
Immunohistochemical analysis of paraffin-embedded human brain tissue using SF1 (Phospho-Ser82) antibody AP55704PU-N (left)or the same antibody preincubated with blocking peptide (right).
Western blot analysis of extracts from HUVEC cells treated with anisomycin using SF1 (Phospho-Ser82) Antibody AP55704PU-N.The lane on the right is treated with the antigen-specific peptide.
Immunohistochemical analysis of SF1 (pS82) staining in human breast cancer formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugad compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
Immunofluorescent analysis of SF1 (pS82) staining in Jurkat cells. Formalin-fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 5-10 minutes and blocked with 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with the primary antibody in 3% BSA-PBS and incubated overnight at 4 deg C in a hidified chamber. Cells were washed with PBST and incubated with a DyLight 594-conjugated secondary antibody (red) in PBS at room temperature in the dark. DAPI was used to stain the cell nuclei (blue).
Immunohistochemistry analysis of paraffin-embedded human brain tissue using SF1 (Ab-82) antibody.The picture on the right is treated with the synthesized peptide.
WB Suggested Anti-SF1 Antibody; Titration: 1.0 ug/ml; Positive Control: Jurkat Whole CellSF1 is supported by BioGPS gene expression data to be expressed in Jurkat
WB Suggested Anti-SF1 Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1:12500; Positive Control: COLO205 cell lysateSF1 is supported by BioGPS gene expression data to be expressed in COLO205
WB Suggested Anti-SF1 Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1: 62500; Positive Control: HepG2 cell lysateSF1 is supported by BioGPS gene expression data to be expressed in HepG2
WB Suggested Anti-SF1 Antibody Titration: 0.2-1 ug/ml; Positive Control: Jurkat cell lysateSF1 is supported by BioGPS gene expression data to be expressed in Jurkat
WB Suggested Anti-SF1 Antibody Titration: 1.25 ug/ml; ELISA Titer: 1: 312500; Positive Control: HepG2 cell lysateSF1 is supported by BioGPS gene expression data to be expressed in HepG2
Western blot analysis of extracts from HUVEC cells, treated with anisomycin (25ug/ml, 30mins), using SF1 (Phospho-Ser82) antibody.The lane on the right is treated with the synthesized peptide.
Immunohistochemistry analysis of paraffin-embedded human brain tissue using SF1 (Phospho-Ser82) antibodyThe picture on the right is treated with the synthesized peptide.
Recombinant protein of human splicing factor 1 (SF1), transcript variant 3
Human
> 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining.
Acris Antibodies GmbH has now officially been renamed to OriGene Technologies GmbH.
Nevertheless, our address and all terms remain the same. Please proceed with selecting and ordering your products as usual or contact us via info-de@origene.com for any additional questions.